Literature DB >> 21428832

Advances in structure-based drug design of novel bacterial topoisomerase inhibitors.

Katherine Widdowson, Alan Hennessy.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 21428832     DOI： 10.4155/fmc.10.250

Source DB:  PubMed          Journal:  Future Med Chem        ISSN： 1756-8919            Impact factor:   3.808


× No keyword cloud information.
  3 in total

1.  Recent Advances in the Rational Design and Optimization of Antibacterial Agents.

Authors:  Jesse A Jones; Kristopher G Virga; Giuseppe Gumina; Kirk E Hevener
Journal:  Medchemcomm       Date:  2016-07-07       Impact factor: 3.597

2.  Topoisomerase II from Human Malaria Parasites: EXPRESSION, PURIFICATION, AND SELECTIVE INHIBITION.

Authors:  Devaraja G Mudeppa; Shiva Kumar; Sreekanth Kokkonda; John White; Pradipsinh K Rathod
Journal:  J Biol Chem       Date:  2015-06-08       Impact factor: 5.157

Review 3.  Exploiting bacterial DNA gyrase as a drug target: current state and perspectives.

Authors:  Frédéric Collin; Shantanu Karkare; Anthony Maxwell
Journal:  Appl Microbiol Biotechnol       Date:  2011-09-09       Impact factor: 4.813
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.